Rainer Kramer
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Dr. Rainer Kramer is a Chief Business Officer at Immatics Biotechnologies GmbH and a Chief Business Officer at Immatics NV.
He is on the Board of Directors at iOmx Therapeutics AG and Immatics US, Inc. Dr. Kramer was previously employed as a Chief Business Officer by Signature Diagnostics AG, a Vice President-Business Development by Jerini AG, a Head-Business Development by MorphoSys AG, and a Principal by Amgen, Inc. He received his undergraduate degree from the University of Regensburg and a doctorate degree from Max Planck Institute of Neurobiology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMATICS N.V. | Corporate Officer/Principal | 01/01/2012 |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Corporate Officer/Principal | 01/04/2012 |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Directeur/Membre du Conseil | - |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur/Membre du Conseil | 20/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Signature Diagnostics AG
Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Operates as a molecular diagnostics company | Corporate Officer/Principal | 01/05/2012 |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Corporate Officer/Principal | 01/08/2009 |
| MORPHOSYS AG | Corporate Officer/Principal | 01/01/2003 |
| AMGEN INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Signature Diagnostics AG
Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Operates as a molecular diagnostics company | Health Technology |
Max Planck Institute of Neurobiology
Max Planck Institute of Neurobiology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national